Dulaglutide Retatrutide KLOW80 TB500 GHK-CU GLOW70 China Fast Delivery High purity Peptide Factory 99%
TDS 62 Inquiries
89030-95-5
Pharmaceutical Grade
99.25%
Chinese mainland
any
Vial/Bottle/Bag/Carton
2026-12-31
Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCopper Tripeptide is a tripeptide molecule rich in copper ions. Its sequence is GHK and it is widely present in human blood, saliva and urine. With age, the concentration of GHK gradually decreases, which is related to the decline of organ regeneration ability. Copper Tripeptide has strong antioxidant capacity, neutralizes free radicals, protects the skin from environmental damage, and with its unique copper ion affinity, it plays a role in promoting wound healing and activating skin regeneration.
Copper tripeptide, also known as [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper or GHK-Cu, is a naturally occurring tripeptide. It was first isolated from human plasma but can be found in saliva and urine. During wound healing, it may be freed from existing extracellular proteins via proteolysis. Studies have shown that GHK-Cu has a maximal biological effect at 10-9mol/L and Its concentration in the body decreases with age[1].CertificatesBasic Info-
Product Name:
Copper tripeptide
Other Name:[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;Ghk-Cu/AHK-CU;Copper tripeptide (GHK-Cu);Prezatide copper,[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;tripeptide/GHK-Cu;Copper peptide, GHK-Cu, Copper tripeptide-1;GHK Copper;GHK.CU.HAC
CAS No.:89030-95-5
Molecular Formula:C14H21CuN6O4
InChIKeys:DDNUEECOCUBKBT-MIIMWFGWNA-L
Molecular Weight:400.91
Exact Mass:402.10800
EC Number:1308068-626-2
Color/Form:Light blue to blue
Categories:
Characteristics-
PSA:
186.03000
XLogP3:1.04530
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
GLP-1 receptor agonist (GLP-1 analog fused to human IgG4-Fc, long-acting)
Status:FDA-approved (Trulicity 2014)
Mechanism:A long-acting GLP-1 receptor agonist consisting of a modified human GLP-1 molecule (7-37) covalently linked to a modified human IgG4 Fc fragment via a small peptide linker. The Fc fusion extends the half-life to ~5 days, allowing once-weekly dosing. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Activity note:Dulaglutide is a dual-agonist with GLP-1R activation. The exact EC50 is proprietary; functional potency is comparable to other long-acting GLP-1R agonists.
Source:DrugBank: DB09095; PubChem CID 16135271.
Clinical Development:FDA:Trulicity (approved 2014-09-18)
References-
DrugBank:PubChem:Disclaimer:
Dulaglutide is FDA-approved as a prescription medicine (Trulicity) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)
-
Location:
Room 1002-C3973, No. 80, Yongtai Modaonan Street, Yongping Subdistrict, Baiyun District, Guangzhou City
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
45
-
Year of Establishment:
2026
-
-
Inquiry History62 Inquiries
Country Product Purchase Quantity Date Posted 
Malaysia
Peptide GHK-Cu Copper Tripeptide-1 Powder CAS 89030-95-5
10 MG Apr 24, 2025 
United States
GHK-Cu
20 MG Aug 12, 2026 
Thailand
Copper Tripeptide-1
2 G Aug 3, 2026
United States
GHK-Cu
30 MG Aug 3, 2026 
Philippines
GHK CU+KPV
10 PCS Jul 19, 2026
United States
Copper Tripeptide
10 MG Jul 14, 2026
United States
Klow
1 MT Jun 27, 2026 
India
Copper Tripeptide-1GHK-Cu (CAS 89030-95-5)
5 KG Jun 22, 2026 
Germany
Copper Tripeptide-1 (GHK-Cu)
20 G Jun 20, 2026
United States
GHK cu
1 MT May 19, 2026 
China
GHK Cu
10000 Apr 21, 2026
China
GHK CU
500 MT Apr 14, 2026 
Brazil
Tripeptídeo de cobre Ghk-Cu
100 MG Mar 25, 2026
Brazil
Ghk cu
1 KG Mar 18, 2026
United States
Ghk cu
1 MG Mar 6, 2026
Philippines
Copper Peptide 99% Blue powder
25 PCS Feb 21, 2026
United States
Ghk cu
10 MG Feb 12, 2026 
Australia
GHKU
20 MT Jan 30, 2026
United States
GHK-Cu
1 G Jul 14, 2025
Malaysia
blue copper peptide GHK-Cu 98% Copper Tripeptide-1
10 MG Apr 24, 2025 Post an enquiry for this product
